AGY — Allergy Therapeutics Share News
0.000.00%
Last trade - 00:00- £706.27m
- £753.56m
- £55.04m
REG - Allergy Therapeutics - NOTICE OF 2022 ANNUAL GENERAL MEETING
AnnouncementREG - AIM Allergy Therapeutics - Suspension - Allergy Therapeutics plc
AnnouncementREG - Allergy Therapeutics - Price Monitoring Extension
AnnouncementREG - Allergy Therapeutics - Second Price Monitoring Extn
AnnouncementREG - Allergy Therapeutics - Second Price Monitoring Extn
AnnouncementREG - Allergy Therapeutics - Price Monitoring Extension
AnnouncementREG - Allergy Therapeutics - Annual Report and Accounts Delayed
AnnouncementREG - Allergy Therapeutics - Director Resignation
AnnouncementREG - Allergy Therapeutics - Key updates on Grass MATA MPL and VLP Peanut
AnnouncementREG - Allergy Therapeutics - Appointment of Non-Executive Directors
AnnouncementREG - Allergy Therapeutics - Appointment of Interim CFO
AnnouncementREG - Allergy Therapeutics - Allergy to resume UK manufacturing production
AnnouncementREG - Allergy Therapeutics - Holding(s) in Company
AnnouncementREG - AIM - AIM Notice - 19/10/2022
AnnouncementREG - Allergy Therapeutics - Allergy Therapeutics – Result of GM
AnnouncementREG - Allergy Therapeutics - UK manufacturing update
AnnouncementRCS - Allergy Therapeutics - Allergy Therapeutics at Investor Meet Company
AnnouncementREG - Allergy Therapeutics - Unaudited Preliminary Results 2022
AnnouncementREG - Allergy Therapeutics - Subscription and Debt Financing
Announcement